Showing results (841-850 of 1,008) with videos related to
Sort By:
Pageof 101
International Journal of Chronic Obstructive Pulmonary Disease|October 13, 2018
Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USABrian J Lipworth, David J Collier, Yasuhiro Gon, et al.Developmental Cell|October 12, 2016
Comparative Principles of DNA Methylation Reprogramming during Human and Mouse In Vitro Primordial Germ Cell SpecificationFerdinand von Meyenn, Rebecca V Berrens, Simon Andrews, et al.Journal of Applied Microbiology|May 7, 2025
Insights into the molecular antimicrobial properties of ferulic acid against Helicobacter pyloriLuay F Abu-Qatouseh, Mohammad I A Ahmad, Célia G Amorim, et al.Annals of Neurology|July 25, 2006
Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeysJeffrey H Kordower, Nicholas M Kanaan, Yaping Chu, et al.BMJ (Clinical Research Ed.)|October 8, 2004
Issues in the reporting of epidemiological studies: a survey of recent practiceStuart J Pocock, Timothy J Collier, Kimberley J Dandreo, et al.Journal of the American Veterinary Medical Association|August 23, 2014
Meta-analysis of the effects of sometribove zinc suspension on the production and health of lactating dairy cowsNormand R St-Pierre, George A Milliken, Dale E Bauman, et al.Protein Science : a Publication of the Protein Society|February 8, 2013
Assembly of anthrax toxin pore: lethal-factor complexes into lipid nanodiscsN Akkaladevi, L Hinton-Chollet, H Katayama, et al.Arxiv|March 13, 2023
Timed material self-assembly controlled by circadian clock proteinsGregor Leech, Lauren Melcher, Michelle Chiu, et al.BMC Cancer|December 13, 2012
Fatal case of sorafenib-associated idiosyncratic hepatotoxicity in the adjuvant treatment of a patient with renal cell carcinomaB P Fairfax, S Pratap, I S D Roberts, et al.European Heart Journal|July 19, 2013
The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trialTimothy J Collier, Stuart J Pocock, John J V McMurray, et al.Pageof 101